Tempus AI, Inc. (TEM)

NASDAQ: TEM · IEX Real-Time Price · USD
40.25
+3.25 (8.78%)
At close: Jun 14, 2024, 4:00 PM
41.35
+1.10 (2.73%)
After-hours: Jun 14, 2024, 7:59 PM EDT
8.78%
Market Cap 6.65B
Revenue (ttm) 562.02M
Net Income (ttm) -293.25M
Shares Out 165.10M
EPS (ttm) -1.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,320,285
Open 40.00
IPO Price 37.00
Day's Range 37.00 - 43.88
52-Week Range 0.03 - 43.88
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About TEM

Tempus AI endeavors to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Our proprietary technology has allowed us to amass what we cons... [Read more]

Sector Healthcare
IPO Date Jun 14, 2024
Employees 2,300
Stock Exchange NASDAQ
Ticker Symbol TEM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Tempus soars 15% on the first day of trading, demonstrating investor appetite for a health tech with a promise of AI

Tempus, a genomic testing and data analysis company started by Eric Lefkosky, who previously founded Groupon, debuted on Nasdaq on Friday, rose about 15% on the opening

8 hours ago - TechCrunch

Tempus AI Surges in Nasdaq Debut Following IPO

Shares of healthcare technology firm Tempus AI surged Friday as they began trading on the Nasdaq.

9 hours ago - Investopedia

Tempus AI shares jump 8% in Nasdaq debut

Shares of SoftBank Group-backed Tempus AI rose 8.1% in their debut on the Nasdaq on Friday, giving the artificial intelligence-based genetic testing company a valuation of $6.6 billion.

12 hours ago - Reuters

Tempus AI CEO Eric Lefkofsky on going public: It's been an incredible journey

Tempus AI founder and CEO Eric Lefkofsky joins 'Squawk Box' to discuss taking the company public on Nasdaq later today, the origin of the company,

15 hours ago - CNBC Television

Tempus AI announces pricing of US IPO

SoftBank Group-backed Tempus AI announced on Thursday the pricing of its initial public offering of 11.1 million ordinary shares at a price of $37 apiece.

1 day ago - Reuters

Tempus Announces Pricing of Initial Public Offering

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (“Tempus”) today announced the pricing of its initial public offering of 11,100,000 shares of its Class A common stock at a public offering price of $37.00 pe...

1 day ago - Business Wire

Healthcare-technology company Tempus AI looks to raise $400 million in IPO

Tempus AI Inc. is about to give investors a way to play the intersection of medicine and artificial intelligence.

9 days ago - Market Watch

Tempus AI seeks up to $6.1 bln valuation in US IPO

Tempus AI is targeting a valuation of up to $6.10 billion in its initial public offering in the United States, the genetics testing company said on Wednesday.

9 days ago - Reuters

Billionaire Groupon founder Lefkofsky is back with another IPO: AI healthtech Tempus

Eric Lefkofsky knows the public listing rodeo well and is about to enter it for a fourth time. The serial entrepreneur, whose net worth is estimated at nearly $4 billion, has already taken three busin...

15 days ago - TechCrunch

Health-tech startup Tempus AI files for a $100 million IPO

Tempus AI, which provides data and analytics tools for precision medicine, filed on Monday with the SEC to raise up to $100 million in an initial public offering.

25 days ago - Renaissance Capital

Tempus AI IPO Registration Document (S-1)

Tempus AI has filed to go public with an IPO on the NASDAQ.

25 days ago - SEC